本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Purple Biotech Ltd.

1.56
-0.0100-0.64%
成交量:1.65萬
成交額:2.54萬
市值:253.79萬
市盈率:-0.05
高:1.56
開:1.54
低:1.52
收:1.57
52周最高:23.60
52周最低:1.16
股本:162.69萬
流通股本:92.71萬
量比:0.78
換手率:1.78%
股息:- -
股息率:- -
每股收益(TTM):-28.8060
每股收益(LYR):-54.9640
淨資產收益率:-111.13%
總資產收益率:-20.31%
市淨率:0.21
市盈率(LYR):-0.03

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/08/30

SEC問詢函

Form CORRESP - Correspondence
2025/08/30

SEC問詢函

Form CORRESP - Correspondence
2025/08/29

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/03/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC問詢函

Form CORRESP - Correspondence
2024/07/22

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC問詢函

Form CORRESP - Correspondence
2023/04/03

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]